Last update 29 Nov 2024
Semaglutide(Sinopep-Allsino)
Last update 29 Nov 2024
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Semaglutide(Sinopep-Allsino)一项评价司美格鲁肽注射液与诺和泰®（Ozempic ®）注射液治疗2型糖尿病的有效性和安全性的多中心、随机、开放、平行分组的Ⅲ期临床试验
[Translation] A multicenter, randomized, open, parallel-group phase III clinical trial to evaluate the efficacy and safety of semaglutide injection and Ozempic ® injection in the treatment of type 2 diabetes
司美格鲁肽注射液与诺和泰®在中国健康受试者中单中心、开放、随机、单剂量、平行设计的药代动力学比对试验
[Translation] A single-center, open-label, randomized, single-dose, parallel-design pharmacokinetic comparison study of semaglutide injection and Novotec® in healthy Chinese subjects
100 Clinical Results associated with Semaglutide(Sinopep-Allsino)
Login to view more data
100 Translational Medicine associated with Semaglutide(Sinopep-Allsino)
Login to view more data
100 Patents (Medical) associated with Semaglutide(Sinopep-Allsino)
Login to view more data
100 Deals associated with Semaglutide(Sinopep-Allsino)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | CN | 28 Nov 2024 | |
| Obesity | IND Approval | CN | 11 Sep 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free